← back to search

Anja Mottok

Universität Ulm · DE
Area of research
Pathology and Forensic Medicine · Genetics
Research interest
Research interests include Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, CAR-T cell therapy research, and Immune Cell Function and Interaction.
h-index
49
citations
9,766
works
235
NIH funding
primary concept
Biology
email

Recent publications

Molecular characterization of Richter syndrome identifies de novo diffuse large B-cell lymphomas with poor prognosis
Nature Communications 2023cited by 35position: middledoi
Focal structural variants revealed by whole genome sequencing disrupt the histone demethylase KDM4C in B-cell lymphomas
Haematologica 2022cited by 7position: middledoi
Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma
Cancer Discovery 2020cited by 158position: middledoi
Lack of NFATc1 SUMOylation prevents autoimmunity and alloreactivity
The Journal of Experimental Medicine 2020cited by 30position: middledoi
BCL2 Expression in First-Line Diffuse Large B-Cell Lymphoma Identifies a Patient Population With Poor Prognosis
Clinical Lymphoma Myeloma & Leukemia 2020cited by 14position: middledoi
Probabilistic cell-type assignment of single-cell RNA-seq for tumor microenvironment profiling
Nature Methods 2019cited by 422position: middledoi
Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition
Cancer Discovery 2019cited by 312position: middledoi
Reproducing the molecular subclassification of peripheral T-cell lymphoma–NOS by immunohistochemistry
Blood 2019cited by 167position: middledoi
Gray-zone Lymphoma Between cHL and Large B-Cell Lymphoma
The American Journal of Surgical Pathology 2018cited by 74position: middledoi
Somatic IL4R mutations in primary mediastinal large B-cell lymphoma lead to constitutive JAK-STAT signaling activation
Blood 2018cited by 60position: middledoi
Loss of the HVEM Tumor Suppressor in Lymphoma and Restoration by Modified CAR-T Cells
Cell 2016cited by 242position: middledoi
Histological Transformation and Progression in Follicular Lymphoma: A Clonal Evolution Study
PLoS Medicine 2016cited by 241position: middledoi
Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion
The Journal of Experimental Medicine 2016cited by 154position: middledoi
Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry
The Lancet Oncology 2015cited by 610position: middledoi
The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development
Nature Medicine 2015cited by 442position: middledoi
Recurrent activating mutations of CD28 in peripheral T-cell lymphomas
Leukemia 2015cited by 128position: middledoi
Genomic Alterations in CIITA Are Frequent in Primary Mediastinal Large B Cell Lymphoma and Are Associated with Diminished MHC Class II Expression
Cell Reports 2015cited by 125position: firstdoi
Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression Profiling
The American Journal of Surgical Pathology 2015cited by 68position: middledoi
Consensus diagnostic histopathological criteria for acute gastrointestinal graft versus host disease improve interobserver reproducibility
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin 2015cited by 43position: middledoi
Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue
Blood 2014cited by 612position: middledoi
Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma
Nature Genetics 2014cited by 195position: middledoi
The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)
Blood 2013cited by 191position: middledoi
Mapping immune processes in intact tissues at cellular resolution
Journal of Clinical Investigation 2012cited by 36position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Randy D. Gascoyne · BC Cancer Agency7 papers (2014–2020)Christian Steidl · BC Cancer Agency6 papers (2014–2019)Lisa M. Rimsza · Mayo Clinic5 papers (2014–2018)Susana Ben‐Neriah · BC Cancer Agency4 papers (2014–2018)Andreas Rosenwald · University of Bonn4 papers (2013–2020) · 3 papers (2014–2018) · 3 papers (2014–2018)Wing C. Chan · Ontario Institute for Cancer Research3 papers (2014–2016)Joseph M. Connors · Spinal Cord Injury BC3 papers (2014–2015)Adèle Telenius · Spinal Cord Injury BC3 papers (2014–2018)Elizabeth A. Chavez · Spinal Cord Injury BC3 papers (2015–2019)German Ott · Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology3 papers (2013–2015)Lauren C. Chong · BC Cancer Agency3 papers (2015–2019)Merrill Boyle · Spinal Cord Injury BC2 papers (2014–2015)Elaine S. Jaffe · National Institutes of Health2 papers (2014–2015)Kai Fu · Yunnan University2 papers (2014–2015)Pedro Farinha · BC Cancer Agency2 papers (2015–2020)Philippe Gaulard · Pitié-Salpêtrière Hospital2 papers (2014–2018)Kerry J. Savage · BC Cancer Agency2 papers (2014–2018)David W. Scott · BC Cancer Agency2 papers (2014–2015)